Sven Rottenberg

Bern, BE 3008, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications

LRRC8A as a candidate biomarker of cisplatin sensitivity in muscle-invasive bladder cancer: an exploratory immunohistochemical study.

LRRC8A as a candidate biomarker of cisplatin sensitivity in muscle-invasive bladder cancer: an exploratory immunohistochemical study.

Journal: International urology and nephrology
Published: June 26, 2026

The oncogenome of the domestic cat.

The oncogenome of the domestic cat.

Journal: Science (New York, N.Y.)
Published: February 19, 2026

Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers.

Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers.

Journal: NPJ precision oncology
Published: February 13, 2026

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

Journal: The Lancet. Oncology
Published: November 20, 2025

Comparative Digital Estrogen Receptor Alpha (ERα) Expression Analysis in Benign and Malignant Prostate Tissue of Men and Dogs.

Comparative Digital Estrogen Receptor Alpha (ERα) Expression Analysis in Benign and Malignant Prostate Tissue of Men and Dogs.

Journal: The Prostate
Published: July 04, 2025

Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer.

Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer.

Journal: Nature communications
Published: May 16, 2025

Spatial transcriptomics and single-nucleus RNA sequencing reveal rAAV2- and rAAV9-specific transduction signatures in the mouse liver.

Spatial transcriptomics and single-nucleus RNA sequencing reveal rAAV2- and rAAV9-specific transduction signatures in the mouse liver.

Journal: Gene therapy
Published: April 16, 2025

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

Journal: Oncogene
Published: April 09, 2025

Mini Review: Spatial Transcriptomics to Decode the Central Nervous System.

Mini Review: Spatial Transcriptomics to Decode the Central Nervous System.

Journal: Toxicologic pathology
Published: March 22, 2025

Points to Consider From the ESTP Pathology 2.0 Working Group: Overview on Spatial Omics Technologies Supporting Drug Discovery and Development.

Points to Consider From the ESTP Pathology 2.0 Working Group: Overview on Spatial Omics Technologies Supporting Drug Discovery and Development.

Journal: Toxicologic pathology
Published: February 11, 2025

Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1.

Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 20, 2024

Nucleophagy removes cytotoxic trapped PARP1.

Nucleophagy removes cytotoxic trapped PARP1.

Journal: Nature cell biology
Published: September 10, 2024
Showing 1-12 of 102

Last Updated: 09/26/2026